5 hours Why Guardant Health Stock Blasted 13% Higher on ThursdayThe Motley Fool
There’s nothing like news of a monster earnings and/or revenue beat to pump a stock’s price higher. That was what happened to cancer-focused biotech Guardant Health (NASDAQ: GH) on Thursday, as its third-quarter earnings release featured far higher-tha…
Biotech · Earnings · Health · Nasdaq 100
X